NCT03573999View on ClinicalTrials.gov

Effect of Mannitol 20% Versus Hypertonic Saline 7.5% in Brain Metabolism and Oxygenation

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 29, 2018

Primary Completion Date

October 31, 2019

Study Completion Date

December 20, 2019

Conditions
Brain EdemaMetabolic DisturbanceElectrolyte and Fluid Balance Conditions
Interventions
DRUG

Mannitol

4.6 ml/kg will be administered before dura opening

DRUG

NaCl 7.5%

2 ml/kg will be administered before dura opening

Trial Locations (2)

56224

AHEPA University Hospital, Thessaloniki

56346

Georgia Tsaousi, Thessaloniki

All Listed Sponsors
lead

Aristotle University Of Thessaloniki

OTHER

NCT03573999 - Effect of Mannitol 20% Versus Hypertonic Saline 7.5% in Brain Metabolism and Oxygenation | Biotech Hunter | Biotech Hunter